Prospective evaluation of Paclitaxel versus combination chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide as neoadjuvant therapy in patients with operable breast cancer. - Buzdar,A.U.; Singletary,S.E.; Theriault,R.L.; Booser,D.J.; Valero,V.; Ibrahim,N.; Smith,T.L.; Asmar,L.; Frye,D.; Manuel,N.; Kau,S.W.; McNeese,M.; et al. (J Clin Oncol, 1999)